ePlus inc. (PLUS) Balance Sheet

As of 2026-06-30 (10-Q), ePlus inc. (PLUS) reported total assets of $1.9B, total liabilities of $795.0M and shareholders' equity of $1.1B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $448.9M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PLUSePlus inc.Follow PLUS — free

Software - Application · Technology

—

Price chart with a free account

Market cap: 2.5B
P/E TTM: 20.0
Dividend yield: 0.8%
52-week: —
Next earnings: 10 Nov, in 16 days

Line	FY2012 Mar 12	FY2013 Mar 13	FY2014 Mar 14	FY2015 Mar 15	FY2016 Mar 16	FY2017 Mar 17	FY2018 Mar 18	FY2019 Mar 19	FY2020 Mar 20	FY2021 Mar 21	FY2022 Mar 22	FY2023 Mar 23	FY2024 Mar 24	FY2025 Mar 25	FY2026 Mar 26	Latest Jun 26
Cash and equivalents	0.03	0.05	0.08	0.08	0.09	0.11	0.12	0.08	0.09	0.13	0.16	0.10	0.25	0.39	0.41	0.45
Short-term investments	0.01	0.00	0.00	—	—	—	—	—	—	—	—	—	—	—	—	—
Receivables	—	0.02	0.03	0.03	0.04	0.02	0.03	0.04	0.04	0.04	0.05	0.50	0.64	0.51	0.65	0.75
Inventory	0.02	0.01	0.02	0.02	0.03	0.09	0.04	0.05	0.05	0.07	0.16	0.24	0.14	0.12	0.20	0.15
Current assets	—	0.32	0.43	0.44	0.48	0.60	0.56	0.56	0.65	0.78	0.90	1.10	1.27	1.36	1.43	1.50
Total assets	0.43	0.44	0.55	0.57	0.62	0.74	0.76	0.79	0.91	1.08	1.17	1.41	1.65	1.88	1.80	1.87
Current liabilities	—	0.17	0.24	0.26	0.27	0.38	0.35	0.33	0.39	0.46	0.46	0.56	0.66	0.80	0.64	0.70
Long-term debt	—	—	—	—	—	—	—	—	—	0.01	0.01	0.01	0.01	0.01	—	—
Total liabilities	0.21	0.20	0.29	0.29	0.30	0.40	0.38	0.36	0.42	0.51	0.51	0.63	0.75	0.91	0.73	0.80
Shareholders' equity	0.22	0.24	0.27	0.28	0.32	0.35	0.37	0.42	0.49	0.56	0.66	0.78	0.90	0.97	1.07	1.07

USD billions · SEC XBRL

ePlus inc. — questions

How much cash does ePlus inc. have?: $448.9M in cash and cash equivalents as of 2026-06-30.
What are ePlus inc.'s total assets?: $1.9B as of 2026-06-30.
What is ePlus inc.'s shareholders' equity?: $1.1B as of 2026-06-30.

Every figure on this page comes from ePlus inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.